BG Medicine Up 9% As Its Galectin-3 Test Aids La Jolla Pharmaceutical Phase 2 Kidney Disease Clinical TrialBy Ryan WallaceMarch 12, 2014 BG Medicine (BGMD) is up 9% after it says it welcomes the positive results from La Jolla Pharmaceutical’s (LJPC) Phase…